Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Mol Neurobiol ; 58(11): 5564-5580, 2021 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-34365584

RESUMO

Traumatic brain injury (TBI) causes neuroinflammation and neurodegeneration leading to various pathological complications such as motor and sensory (visual) deficits, cognitive impairment, and depression. N-3 polyunsaturated fatty acid (n-3 PUFA) containing lipids are known to be anti-inflammatory, whereas the sphingolipid, ceramide (Cer), is an inducer of neuroinflammation and degeneration. Using Fat1+-transgenic mice that contain elevated levels of systemic n-3 PUFA, we tested whether they are resistant to mild TBI-mediated sensory-motor and emotional deficits by subjecting Fat1-transgenic mice and their WT littermates to focal cranial air blast (50 psi) or sham blast (0 psi, control). We observed that visual function in WT mice was reduced significantly following TBI but not in Fat1+-blast animals. We also found Fat1+-blast mice were resistant to the decline in motor functions, depression, and fear-producing effects of blast, as well as the reduction in the area of oculomotor nucleus and increase in activated microglia in the optic tract in brain sections seen following blast in WT mice. Lipid and gene expression analyses confirmed an elevated level of the n-3 PUFA eicosapentaenoic acid (EPA) in the plasma and brain, blocking of TBI-mediated increase of Cer in the brain, and decrease in TBI-mediated induction of Cer biosynthetic and inflammatory gene expression in the brain of the Fat1+ mice. Our results demonstrate that suppression of ceramide biosynthesis and inflammatory factors in Fat1+-transgenic mice is associated with significant protection against the visual, motor, and emotional deficits caused by mild TBI. This study suggests that n-3 PUFA (especially, EPA) has a promising therapeutic role in preventing neurodegeneration after TBI.


Assuntos
Sintomas Afetivos/prevenção & controle , Concussão Encefálica/sangue , Caderinas/fisiologia , Ácidos Graxos Ômega-3/sangue , Traumatismos Cranianos Fechados/sangue , Transtornos dos Movimentos/prevenção & controle , Transtornos da Visão/prevenção & controle , Sintomas Afetivos/sangue , Sintomas Afetivos/etiologia , Animais , Química Encefálica , Concussão Encefálica/complicações , Concussão Encefálica/psicologia , Caderinas/genética , Ceramidas/biossíntese , Depressão/sangue , Depressão/etiologia , Depressão/prevenção & controle , Resistência à Doença , Ácidos Graxos Ômega-3/fisiologia , Medo , Feminino , Traumatismos Cranianos Fechados/complicações , Traumatismos Cranianos Fechados/psicologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Transtornos dos Movimentos/sangue , Transtornos dos Movimentos/etiologia , Doenças Neuroinflamatórias , Teste de Campo Aberto , Estresse Oxidativo , Proteínas Recombinantes/metabolismo , Esfingolipídeos/análise , Esfingomielina Fosfodiesterase/análise , Transtornos da Visão/sangue , Transtornos da Visão/etiologia
2.
J Pediatr Gastroenterol Nutr ; 61(4): 472-80, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-25988553

RESUMO

OBJECTIVES: The aim of the present study was to elucidate whether a dairy drink enriched with ω-3 long-chain polyunsaturated fatty acid (LC-PUFA) could have an impact on the lipid profile of the mother and the newborn, and also whether this intervention could affect the newborns' visual and cognitive development. METHODS: A total of 110 pregnant women were randomly assigned to one of the following intervention groups: control group (n = 54), taking 400 mL/day of the control dairy drink, and supplemented group (fish oil [FO]) (n = 56), taking 400 mL/day of the fish oil-enriched dairy drink (including ∼400 mg eicosapentaenoic acid-docosahexaenoic acid [DHA]/day). During the study, the mothers' diets were supervised by a nutritionist to encourage compliance with present recommendations of FA intake. Blood fatty acid profiles were determined in the mother's (at enrollment, at delivery, and at 2.5 and 4 months) and newborn (at delivery and at 2.5 months) placenta and breast milk (colostrum and at 1, 2, and 4 months). Pattern reversal visual evoked potentials (VEPs) (at 2.5 and 7.5 months) and Bayley test (at 12 months) were recorded. RESULTS: DHA percentage was higher in plasma, erythrocyte membranes, and breast milk samples from the FO group. The ratio of nervonic acid was also higher in plasma and erythrocyte lipids of the mother and newborn's blood samples from the FO group. No differences were observed in the Bayley test. No differences were observed in VEPs between both groups. We observed a shorter latency, however, in the lower visual angle (7.5') in the boys of the supplemented group. CONCLUSIONS: Omega-3 LC-PUFA dietary supplement during pregnancy and lactation influenced the mother and newborn's fatty acid profile and nervonic acid content but did not show effects on visual and cognitive/psychomotor development.


Assuntos
Desenvolvimento Infantil , Ácidos Graxos Ômega-3/uso terapêutico , Desenvolvimento Fetal , Alimentos Fortificados , Lactação , Fenômenos Fisiológicos da Nutrição Materna , Neurogênese , Bebidas , Transtornos Cognitivos/sangue , Transtornos Cognitivos/metabolismo , Transtornos Cognitivos/prevenção & controle , Colostro/química , Laticínios , Método Duplo-Cego , Potenciais Evocados Visuais , Ácidos Graxos/análise , Ácidos Graxos/sangue , Ácidos Graxos/metabolismo , Ácidos Graxos Ômega-3/administração & dosagem , Ácidos Graxos Ômega-3/análise , Ácidos Graxos Ômega-3/metabolismo , Feminino , Óleos de Peixe/administração & dosagem , Óleos de Peixe/metabolismo , Óleos de Peixe/uso terapêutico , Humanos , Recém-Nascido , Masculino , Leite Humano/química , Placenta/metabolismo , Gravidez , Transtornos da Visão/sangue , Transtornos da Visão/metabolismo , Transtornos da Visão/prevenção & controle
3.
Ophthalmic Epidemiol ; 20(1): 4-12, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23350550

RESUMO

PURPOSE: To estimate the prevalence of optic neuropathy (ON) among prisoners in a provincial prison in Papua New Guinea, and to explore risk factors for this condition among this population. METHODS: Cross-sectional observation study of 148 male prisoners aged ≥18 years using an interview-based questionnaire, assessment of visual and nervous system function, ocular examination, and blood analysis (α-tocopherol, ß-carotene, lutein, folate, homocysteine, holotranscobalamin II, riboflavin, selenium, thiamin, and vitamins A, B(12) and C). Likelihood of the presence of ON was based on ordered groups determined by weighted combination of optic nerve head appearance and visual dysfunction (acuity, field, color perception). Main outcome measures were prevalence and associations of ON. RESULTS: Sample prevalence of clinical ON was 10.4% (95% confidence interval [CI], 6.2-16.8). No cases were found of unexplained non-visual nervous system dysfunction, including peripheral neuropathy. Increasing age (p = 0.001), length of current (p = 0.002) and lifetime (p = 0.03) incarceration, and duration of smoking by current smokers (p = 0.001) were associated with increased ON likelihood. However, when age-controlled, the smoking duration association was not maintained (p = 0.6). Prisoners were folate deficient. Adjusting for age and duration of current incarceration, whole blood (p = 0.02) and red blood cell (p = 0.04) folate concentrations were inversely associated with ON likelihood. No association was found for any other assessed demographic, lifestyle or biochemical measure. CONCLUSIONS: A cluster of ON associated with folate deficiency has been identified. Recommendations for dietary change and micronutrient supplementation have been made.


Assuntos
Doenças do Nervo Óptico/epidemiologia , Prisioneiros/estatística & dados numéricos , Adulto , Estudos Transversais , Feminino , Ácido Fólico/sangue , Deficiência de Ácido Fólico/sangue , Deficiência de Ácido Fólico/epidemiologia , Humanos , Luteína/sangue , Masculino , Doenças do Nervo Óptico/sangue , Papua Nova Guiné/epidemiologia , Prevalência , Fatores de Risco , Selênio/sangue , Inquéritos e Questionários , Transtornos da Visão/sangue , Transtornos da Visão/epidemiologia , Vitamina A/sangue , Vitamina B 12/sangue , alfa-Tocoferol/sangue , beta Caroteno/sangue
4.
Clin Exp Ophthalmol ; 28(1): 62-4, 2000 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11345350

RESUMO

Hypovitaminosis A is a well-recognized condition in many developing countries. However, in the developed world the diagnosis is frequently missed or delayed because of its rarity. A 67-year-old man from metropolitan Adelaide presented to us with gradual but severe bilateral visual loss. He had marked punctate epithelial keratopathy in both eyes. Hypovitaminosis was suspected because of his bizarre dietary habit, and this was confirmed by a combination of impression cytology of the ocular surface and biochemical testing of his venous blood. His vision responded dramatically to vitamin A supplementation. Hypovitaminosis A should be suspected in severe cases of 'dry-eye', especially in those patients with unusual dietary habit or malabsorption.


Assuntos
Transtornos da Visão/diagnóstico , Deficiência de Vitamina A/diagnóstico , Xeroftalmia/diagnóstico , Idoso , Humanos , Masculino , Austrália do Sul , Transtornos da Visão/sangue , Transtornos da Visão/tratamento farmacológico , Vitamina A/sangue , Vitamina A/uso terapêutico , Deficiência de Vitamina A/sangue , Deficiência de Vitamina A/tratamento farmacológico , Xeroftalmia/sangue , Xeroftalmia/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA